Sandbox carlos: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 2: Line 2:


{{PBI|Cytoisospora belli}}
{{PBI|Cytoisospora belli}}
:*'''Immunocompetent'''
:*'''Immunocompetent'''<ref></ref>
::* Prefered regimen: [[Trimethoprim-sulfamethoxazole]] 160 mg/800 mg PO {{or}} IV qid for 10 days
::* Prefered regimen: [[Trimethoprim-sulfamethoxazole]] 160 mg/800 mg PO {{or}} IV qid for 10 days


*patients with sulfa intolerance
*patients with sulfa intolerance
Line 14: Line 14:
*In Patients with CD4 Count <200/mm3 (chronic treatment)
*In Patients with CD4 Count <200/mm3 (chronic treatment)
::* Prefered regimen: [[Trimethoprim-sulfamethoxazole]] 160 mg/800 mg PO 3 times weekly  
::* Prefered regimen: [[Trimethoprim-sulfamethoxazole]] 160 mg/800 mg PO 3 times weekly  
::* Alternative regimen (1): [[Trimethoprim-sulfamethoxazole]] 320 mg/1600 mg PO 3 times weekly  
::* Alternative regimen (1): [[Trimethoprim-sulfamethoxazole]] 320 mg/1600 mg PO 3 times weekly  
::* Alternative regimen (2): [[Pyrimethamine]] 25 mg PO daily {{and}} Leucovorin 5–10 mg PO daily   
::* Alternative regimen (2): [[Pyrimethamine]] 25 mg PO daily {{and}} Leucovorin 5–10 mg PO daily   
::* Alternative regimen (3): [[Ciprofloxacin]] 500 mg PO 3 times weekly  
::* Alternative regimen (3): [[Ciprofloxacin]] 500 mg PO 3 times weekly  



Revision as of 15:40, 16 July 2015


  • Immunocompetent
  • patients with sulfa intolerance
  • Alternative regimen (1): Pyrimethamine 50-75 mg PO daily AND Leucovorin 10–25 mg PO daily
  • Alternative regimen (2): Ciprofloxacin 500 mg PO BID for 7 days


  • HIV
  • In Patients with CD4 Count <200/mm3 (chronic treatment)


References